NCT00361517View on ClinicalTrials.gov

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 1, 2006

Primary Completion Date

October 30, 2007

Study Completion Date

June 30, 2009

Conditions
Aspergillosis
Interventions
BEHAVIORAL

Galactomannan antigen monitoring, Aspergillus PCR

There will be blood draws twice weekly for monitoring GM antigen and once a week for Aspergillus PCR.

OTHER

blood draws

Blood is drawn for monitoring of Galactomannan antigen in the blood

OTHER

blood draws for GM monitoring

blood samples will be taken twice weekly for monitoring of GM antigen levels in the blood and once a week for Aspergillus PCR.

DRUG

Amphotericin-B deoxycholate

1-1.5mg/kg, i.v, once a day

OTHER

blood test

Blood will be tested twice a week for the presence of Galactomannan.

OTHER

Blood test

Blood will be drawn twice a week and it will be tested for the presence of GM(a component of the cell wall of the mold Aspergillus which is released during growth)

Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
collaborator

National University Hospital, Singapore

OTHER

lead

Singapore General Hospital

OTHER

NCT00361517 - To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early | Biotech Hunter | Biotech Hunter